(UNCY) announced Monday that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for Oxylanthanum Carbonate (OLC). The FDA has set a Prescription Drug User Fee ...
Title: Combination Oxylanthanum Carbonate and Tenapanor Lowers Urinary ... The study demonstrated potent effects of the novel lanthanum-based phosphate binder OLC and found that OLC plus tenapanor ...
Drug major Cipla is recalling over 1,800 boxes of a generic medication in the US due to complaints of broken tablets, according to the US health regulator. As per the latest Enforcement Report by the ...